Cambridge Enterprise appoints new Chief Executive
Dr Jim Glasheen has been appointed as Chief Executive of Cambridge Enterprise, the innovation arm of the University of Cambridge. Dr Glasheen will assume his post later in 2024.
Harnessing sunlight to digest plastics and a smart fitness device for your brain: meet the 11 start-ups selected from the first Founders at the University of Cambridge Start 1.0 accelerator
Founders at the University of Cambridge welcomes eleven innovative companies to the Start Accelerator 1.0 programme The start-ups, al
Cambridge Enterprise Chief Executive appointed new Pro-Vice-Chancellor for Innovation
Cambridge Enterprise Chief Executive Dr Diarmuid O’Brien has been appointed as the University of Cambridge’s new Pro-Vice-Chancellor for Innovation.
100 experts from Graphcore, Arm, Google and Stripe come together to support the next generation of Cambridge startups
Founders at the University of Cambridge opens applications to its first pre-seed accelerator.
Tech ecosystem champion Gerard Grech to lead flagship Founders initiative
The University of Cambridge is delighted to announce that Gerard Grech, former CEO of Tech Nation, has joined Cambridge Enterprise to lead a new flagship initiative that will support and accelerate University founders to make an even greater impact on the world in the technology and software sectors.
Cambridge Enterprise celebrates a year of innovation and economic growth
Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements.
Survey to gather insights on the long term innovation vision for Cambridge
Innovate Cambridge writes...As part of the Innovate Cambridge process, we would like to gather your insights and to do this we are launching two short surveys. These will provide an opportunity to highlight the issues that matter most to you and your organisation.
Cambridge Enterprise licenses unique new device for cancer diagnosis
Transforming the process of prostate cancer diagnosis - this month will see the launch of a revolutionary device that is set to transform the process of prostate cancer diagnosis. The Cambridge Prostate Biopsy Device (CamPROBE) is designed to reduce the risk of infection, compared with traditional transrectal biopsies, and improve the experience for patients. The cost is also expected to be less…
Cambridge Enterprise, Cambridge Innovation Capital, and the University of Cambridge launches ‘Innovate Cambridge’
Innovate Cambridge is an ambitious Greater Cambridge initiative that aims to collectively agree on and define an inclusive vision for the future of Cambridge and its innovation ecosystem to be implemented over the next decade.
Cambridge Enterprise leads £1m investment in cancer care management device start-up
52 North Health, a UK and US-based med-tech start-up, has raised £1 million in its first round of funding from leading UK and European specialist investors.
Zero-carbon refrigeration pioneer Barocal secures £1.3m funding to explore heating systems
Zero-carbon refrigeration pioneer Barocal secures a £1.3 million investment to accelerate commercialisation of its novel technology designed to dramatically cut global CO₂ emissions.
New grafting technique could combat the disease threatening Cavendish bananas
Scientists have found a novel way to combine two species of grass-like plant including banana, rice and wheat, using embryonic tissue from their seeds. The technique allows beneficial characteristics, such as disease resistance or stress tolerance, to be added to the plants.
Ceres Agri-Tech launches first three spin-outs
The first three spin-out companies have been launched from a government-backed knowledge exchange partnership designed to revolutionise the creation and uptake of early-stage agricultural technology (agri-tech) opportunities.
Cambridge Enterprise invests in Carbon Re, start-up cutting CO₂ emissions by gigatonnes
The University of Cambridge Enterprise Fund has joined in a £1 million investment in Carbon Re, a UK climate tech start-up that uses artificial intelligence to cut CO₂ emissions in the global cement industry and other hard-to-abate industrial processes. The investment will accelerate development of Carbon Re’s AI technology to help the global cement industry and other energy intensive industries…
University spin-out Echion Technologies raises £10m in Series A investment round
Funding will accelerate development of next-generation lithium-ion battery technology.
Semi-finalists announced in 2021 Chris Abell Postdoc Business Plan Competition
Thirteen semi-finalists have been announced for the 2021 Chris Abell Postdoc Business Plan Competition run by Cambridge Enterprise.
University of Cambridge appoints Dr Diarmuid O’Brien as new Chief Executive of Cambridge Enterprise
The University of Cambridge announces the appointment of Dr Diarmuid O’Brien as the new Chief Executive of Cambridge Enterprise, effective September 2021.
Cambridge spin-out HexagonFab secures £1.9m seed funding to launch the Bolt
University of Cambridge spin-out company HexagonFab today announced a £1.9 million seed funding round, led by Cambridge Enterprise, joined by Parkwalk, New Grounds VC, Silicon Valley-based R42 Group, and several private investors.
Cambridge spin-out SMAP Energy acquired by ENECHANGE
ENECHANGE has acquired 100% of share capital and acquisition rights in SMAP Energy, making the company a wholly owned subsidiary.
University spin-out Cambridge GaN Devices raises $9.5m in Series A investment round
Cambridge GaN Devices (CGD) has raised $9.5 million in Series A funding. The investment was co-led by IQ Capital, Parkwalk Advisors, and BGF and joined by Cambridge Enterprise, Foresight Williams, Martlet Capital, Cambridge Angels, and Cambridge Capital Group. CGD will use the funding to expand its product portfolio of energy-efficient power devices and to double the size of its team.
Three Cambridge spin-outs join Centessa Pharmaceuticals, launched with a $250m Series A round
ApcinteX, Morphogen-IX, Z Factor join seven other privately held biotech companies in a new type of pharmaceutical R&D model.
Cambridge launches eighth Enterprise fund
The University of Cambridge has launched its eighth Enterprise Fund, managed by university spinout fund manager Parkwalk in conjunction with Cambridge Enterprise, the University’s Technology Transfer Office.
Cambridge spin-out ApcinteX shares clinical trial results from its study of SerpinPC
ApcinteX Ltd, a biotech company spun out of the University of Cambridge, today announced the results from Part I of its ongoing clinical trial, AP-0101, assessing the safety, tolerability, and pharmacokinetics of its investigational drug SerpinPC in healthy volunteers and patients with severe haemophilia A and B.
GlycoVue wins the 2020 Cambridge Enterprise Postdoc Business Plan Competition
GlycoVue, which combines glucose-responsive smart polymers with advanced holography and AI-enabled smartphone technology for diabetes self-management, has won the £20,000 first prize in the 2020 Cambridge Enterprise Postdoc Business Plan Competition.
Psyomics secures £1.5m funding to transform mental health diagnosis in the UK
Psyomics Ltd, a UK-based healthtech and University of Cambridge spin-out, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. University spinout specialists Parkwalk led the round, joined by fellow existing investors Jonathan Milner, Martlet, and Cambridge Enterprise.